Drugs@FDA document
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE Letter · ANDA 203136 SUPPL-3
Drugs@FDA document · AMNEAL PHARMS · May 29, 2014
Key facts
| Drug name | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE |
|---|---|
| Document type | Letter |
| Application | ANDA203136 |
| Submission | SUPPL-3 |
| Company | AMNEAL PHARMS |
| Document date | May 29, 2014 |
| FDA document | accessdata.fda.gov |
At a glance
- Manufacturing (CMC) Document categories
- 10–99 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: